World Health Organization and beyond: new aspects in the pathology of an old disease.
Hodgkin's lymphoma is a highly enigmatic lymphoma disease that still covers most of its secrets up to now. Much effort has been made to successfully wrest at least some of the pathogenetic particularities. The current diagnostic criteria are well established allowing hemato-pathologists to make a clear-cut distinction from other lymphomas in almost all cases. Although classic Hodgkin's lymphoma is curable in the vast majority of cases by treatment with highly aggressive drugs with or without radiotherapy, further molecular studies may lead to the identification of therapeutic targets that enable a more tailored treatment with fewer side effects.
Hummel
Michael
M
Institute of Pathology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany. michael.hummel@charite.de
D049672:History, 19th Century; D049673:History, 20th Century; D006689:Hodgkin Disease / Q000145:classification / Q000175:diagnosis / Q000266:history / Q000473:pathology*; D006801:Humans; D016130:Immunophenotyping; D008198:Lymph Nodes / Q000473:pathology*; D016539:Reed-Sternberg Cells / Q000145:classification / Q000473:pathology*; D014944:World Health Organization